Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | AB-16B5 + Docetaxel |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AB-16B5 | AB 16B5|AB16B5 | AB-16B5 is a monoclonal antibody that binds to and inhibits the activity of human clusterin (sCLU), resulting in inhibition of tumor cell proliferation and metastasis (NCI Drug Dictionary). | ||
Docetaxel | Taxotere | RP56976 | Antimicrotubule Agent 14 | Taxotere (docetaxel) binds to tubulin, inhibiting microtubule disassembly and preventing cell division (PMID: 32496783, PMID: 32366558). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04364620 | Phase II | AB-16B5 + Docetaxel | AB-16B5 Combined With Docetaxel in Subjects With Metastatic Non-Small Cell Lung Cancer | Active, not recruiting | USA | CAN | 0 |